ToolGen Inc.
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, … Read more
Market Cap & Net Worth: ToolGen Inc. (199800)
ToolGen Inc. (KQ:199800) has a market capitalization of $289.50 Million (₩423.88 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #14280 globally and #397 in its home market, demonstrating a 6.70% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ToolGen Inc.'s stock price ₩48600.00 by its total outstanding shares 8721847 (8.72 Million).
ToolGen Inc. Market Cap History: 2021 to 2026
ToolGen Inc.'s market capitalization history from 2021 to 2026. Data shows change from $539.68 Million to $289.50 Million (-13.69% CAGR).
Index Memberships
ToolGen Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.14% | #136 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.14% | #136 of 1384 |
Weight: ToolGen Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ToolGen Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ToolGen Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.26x
ToolGen Inc.'s market cap is 0.26 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.04x
ToolGen Inc.'s market cap is 0.04 times its annual earnings
0.11x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $539.68 Million | $1.60 Billion | -$20.69 Billion | 0.34x | N/A |
| 2022 | $327.02 Million | $743.46 Million | -$18.18 Billion | 0.44x | N/A |
| 2023 | $418.16 Million | $1.10 Billion | -$42.34 Billion | 0.38x | N/A |
| 2024 | $227.84 Million | $890.96 Million | $6.23 Billion | 0.26x | 0.04x |
Competitor Companies of 199800 by Market Capitalization
Companies near ToolGen Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to ToolGen Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ToolGen Inc. Historical Marketcap From 2021 to 2026
Between 2021 and today, ToolGen Inc.'s market cap moved from $539.68 Million to $ 289.50 Million, with a yearly change of -13.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩289.50 Million | -17.06% |
| 2025 | ₩349.06 Million | +53.20% |
| 2024 | ₩227.84 Million | -45.51% |
| 2023 | ₩418.16 Million | +27.87% |
| 2022 | ₩327.02 Million | -39.40% |
| 2021 | ₩539.68 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ToolGen Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $289.50 Million USD |
| MoneyControl | $289.50 Million USD |
| MarketWatch | $289.50 Million USD |
| marketcap.company | $289.50 Million USD |
| Reuters | $289.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.